Protein expression and subcellular localization of familial acute myelogenous leukemia-related factor

被引:4
作者
Huang, Yuanmao [1 ]
Chen, Lulu [1 ]
Ye, Meiling [1 ]
Lin, Shenglong [1 ]
Zi, Youmei [1 ]
Wang, Shaoyuan [1 ,2 ]
机构
[1] Fujian Med Univ, Union Clin Med Coll, Fuzhou 350001, Peoples R China
[2] Fujian Med Univ, Fujian Inst Hematol, Dept Hematol, Union Hosp, Fuzhou 350001, Peoples R China
基金
中国国家自然科学基金;
关键词
familial acute myeloid leukemia; FAMLF; antibody; nuclear expression; ACUTE MYELOID-LEUKEMIA; MUTATIONS; GENE; FLT3; AML; PEDIGREE; RELAPSE; ADULTS; CELLS; MODEL;
D O I
10.3892/or.2013.2773
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study was designed to evaluate the expression and subcellular distribution of the familial acute myelogenous leukemia-related factor (FAMLF). A 14-amino acid epitope of the predicted open reading frame of the FAMLF gene was identified using bioinformatics. This polypeptide was synthesized, conjugated to keyhole limpet hemocyanin and was subsequently used to produce antibodies. The antibody titer and specificity were characterized using ELISA and western blot assays, respectively. The antibody detected FAMLF protein expression in several human leukemia cell lines, bone marrow cells derived from one acute myeloid leukemia patient and one chronic myeloid leukemia patient, but not in bone marrow cells of healthy subjects. The FAMLF/GFP fusion protein was expressed in both the nucleus and the cytoplasm of transfected NIH3T3 cells. Our results demonstrate that the FAMLF gene is expressed in an AML patient but not in healthy controls, suggesting its association with AML.
引用
收藏
页码:2672 / 2676
页数:5
相关论文
共 22 条
  • [1] BIRG F, 1992, BLOOD, V80, P2584
  • [2] Prognostic impact of c-KIT mutations in core binding factor leukemas:: an Italian retrospective study
    Cairoli, R
    Beghini, A
    Grillo, G
    Nadali, G
    Elice, F
    Ripamonti, CB
    Colapietro, P
    Nichelatti, M
    Pezzetti, L
    Lunghi, M
    Cuneo, A
    Viola, A
    Ferrara, F
    Lazzarino, M
    Rodeghiero, F
    Pizzolo, G
    Larizza, L
    Morra, E
    [J]. BLOOD, 2006, 107 (09) : 3463 - 3468
  • [3] Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
    Doehner, Hartmut
    Estey, Elihu H.
    Amadori, Sergio
    Appelbaum, Frederick R.
    Buechner, Thomas
    Burnett, Alan K.
    Dombret, Herve
    Fenaux, Pierre
    Grimwade, David
    Larson, Richard A.
    Lo-Coco, Francesco
    Naoe, Tomoki
    Niederwieser, Dietger
    Ossenkoppele, Gert J.
    Sanz, Miguel A.
    Sierra, Jorge
    Tallman, Martin S.
    Loewenberg, Bob
    Bloomfield, Clara D.
    [J]. BLOOD, 2010, 115 (03) : 453 - 474
  • [4] Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus-negative leukemia cell lines
    Furukawa, Y.
    Vu, H. A.
    Akutsu, M.
    Odgerel, T.
    Izumi, T.
    Tsunoda, S.
    Matsuo, Y.
    Kirito, K.
    Sato, Y.
    Mano, H.
    Kano, Y.
    [J]. LEUKEMIA, 2007, 21 (05) : 1005 - 1014
  • [5] No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials
    Gale, RE
    Hills, R
    Kottaridis, PD
    Srirangan, S
    Wheatley, K
    Burnett, AK
    Linch, DC
    [J]. BLOOD, 2005, 106 (10) : 3658 - 3665
  • [6] Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia
    Hahn, Christopher N.
    Chong, Chan-Eng
    Carmichael, Catherine L.
    Wilkins, Ella J.
    Brautigan, Peter J.
    Li, Xiao-Chun
    Babic, Milena
    Lin, Ming
    Carmagnac, Amandine
    Lee, Young K.
    Kok, Chung H.
    Gagliardi, Lucia
    Friend, Kathryn L.
    Ekert, Paul G.
    Butcher, Carolyn M.
    Brown, Anna L.
    Lewis, Ian D.
    To, L. Bik
    Timms, Andrew E.
    Storek, Jan
    Moore, Sarah
    Altree, Meryl
    Escher, Robert
    Bardy, Peter G.
    Suthers, Graeme K.
    D'Andrea, Richard J.
    Horwitz, Marshall S.
    Scott, Hamish S.
    [J]. NATURE GENETICS, 2011, 43 (10) : 1012 - U130
  • [7] Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia
    Holme, Harriet
    Hossain, Upal
    Kirwan, Michael
    Walne, Amanda
    Vulliamy, Tom
    Dokal, Inderjeet
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (02) : 242 - 248
  • [8] Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide
    Karp, Judith E.
    Flatten, Karen
    Feldman, Eric J.
    Greer, Jacqueline M.
    Loegering, David A.
    Ricklis, Rebecca M.
    Morris, Lawrence E.
    Ritchie, Ellen
    Smith, B. Douglas
    Ironside, Valerie
    Talbott, Timothy
    Roboz, Gail
    Le, Son B.
    Meng, Xue Wei
    Schneider, Paula A.
    Dai, Nga T.
    Adjei, Alex A.
    Gore, Steven D.
    Levis, Mark J.
    Wright, John J.
    Garrett-Mayer, Elizabeth
    Kaufmann, Scott H.
    [J]. BLOOD, 2009, 113 (20) : 4841 - 4852
  • [9] Li Jing-gang, 2008, Zhonghua Yi Xue Za Zhi, V88, P2667
  • [10] Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
    Marcucci, Guido
    Maharry, Kati
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Vukosavljevic, Tamara
    Paschka, Peter
    Whitman, Susan P.
    Langer, Christian
    Baldus, Claudia D.
    Liu, Chang-Gong
    Ruppert, Amy S.
    Powell, Bayard L.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Kolitz, Jonathan E.
    Larson, Richard A.
    Bloomfield, Clara D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (31) : 5078 - 5087